Innovation

Adaptive Optics for Optical Coherence Tomography

Massachusetts General Hospital
posted on 07/06/2011

Technology: Innovators from the Wellman Center for Photomedicine developed a polarization sensitive optical coherence tomography (PS-OCT) system that incorporated adaptive optics. This adaptive optics approach uses the core and the cladding of a fiber to correct for wave front aberrations rather than use a wave front sensor, like other adaptive optic approaches. When incorporated into the PS-OCT system, the adaptive optics generate an improved image quality and sharpness because it increases the signal-to-noise ration, produces a higher lateral resolution and decreases speckle size. Application: ophthalmic imaging, more specifically diagnosis and management of Glaucoma. Advantages: - Improved image quality and sharpness enables better disease diagnosis and management. - Simple design decreases the complexity and cost of a PS-OCT system. Publication: Cense B., (Retinal imaging with polarization-sensitive optical coherence tomography and adaptive optics) Opt Express; 2009 Nov 23; 17(24):21634-51.


Innovation Details
 

File Number: 03623 

Other Information: *Investigator(s)*
Johannes F. de Boer

*Contact*
William Shaw, 617-954-9336


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Mary Auge at Massachusetts General Hospital for more information.

Request more info via email request more info
People

Case Manager:

Mary Auge Mary Auge

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...